Amag Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amag Pharmaceuticals ( AMAG) is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). This stock is trading up 4.3% at $15.93 in recent trading.

Today's Volume: 148,000

Average Volume: 113,246

Volume % Change: 159%

Shares of AMAG are moving sharply higher today after the company announced a positive CHMP opinion for the approval of ferumoxytol in Europe for the treatment of iron deficiency anemia in adult patients with chronic kidney disease.

>>7 Hot STocks on Traders' Radars

From a technical perspective, AMAG is bouncing hard of some previous support levels near $15 to $15.15 today with above average volume. This move is pushing the stock within range of both its 200-day and 50-day moving averages.

Traders should now look for long-biased trades if AMAG can manage to sustain a move or close above its 200-day at $15.99 and its 50-day at $16.05 with high-volume. Look for volume that's near or well above 113,246 shares. If we get that action soon, look for AMAG to make a run at $17 to $18 in the near-term.

If you liked this article you might like

How to Trade Monday's Most Active Stocks -- Rite Aid, BofA, Fitbit, More

Keysight Technologies to Grab Ixia for $1.6 Billion

Cisco Investors Watch Earnings for Look Into the IT Market, Trump's Tech Effect

Here's Why Ixia (XXIA) Stock Is Tanking Today

Insider Trading Alert - DXYN, XXIA And NTWK Traded By Insiders